173 related articles for article (PubMed ID: 28966682)
1. Prophylactic ulinastatin administration for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis.
Zhu K; Wang JP; Su JG
Exp Ther Med; 2017 Oct; 14(4):3036-3056. PubMed ID: 28966682
[TBL] [Abstract][Full Text] [Related]
2. Preventive effect of ulinastatin and gabexate mesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis.
Zhang ZF; Yang N; Zhao G; Zhu L; Zhu Y; Wang LX
Chin Med J (Engl); 2010 Sep; 123(18):2600-6. PubMed ID: 21034635
[TBL] [Abstract][Full Text] [Related]
3. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis.
Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X
Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097
[TBL] [Abstract][Full Text] [Related]
4. Role of ulinastatin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: the Emperor's New Clothes or Aladdin's Magic Lamp?
Chen S; Shi H; Zou X; Luo H
Pancreas; 2010 Nov; 39(8):1231-7. PubMed ID: 20531245
[TBL] [Abstract][Full Text] [Related]
5. The use of gabexate mesylate and ulinastatin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Yoo YW; Cha SW; Kim A; Na SY; Lee YW; Kim SH; Lee HIe; Lee YJ; Yang HW; Jung SH
Gut Liver; 2012 Apr; 6(2):256-61. PubMed ID: 22570757
[TBL] [Abstract][Full Text] [Related]
6. Comparison between ulinastatin and nafamostat for prevention of post-endoscopic retrograde cholangiopancreatography complications: a prospective, randomized trial.
Park JY; Jeon TJ; Hwang MW; Sinn DH; Oh TH; Shin WC; Choi WC
Pancreatology; 2014; 14(4):263-7. PubMed ID: 25062874
[TBL] [Abstract][Full Text] [Related]
7. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
8. Role of Somatostatin in Preventing Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis: An Update Meta-analysis.
Hu J; Li PL; Zhang T; Chen JP; Hu YJ; Yu Z; Wang JP; Zhu D; Tong XF
Front Pharmacol; 2016; 7():489. PubMed ID: 28018225
[No Abstract] [Full Text] [Related]
9. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
[TBL] [Abstract][Full Text] [Related]
10. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial.
Yoo JW; Ryu JK; Lee SH; Woo SM; Park JK; Yoon WJ; Lee JK; Lee KH; Hwang JH; Kim YT; Yoon YB
Pancreas; 2008 Nov; 37(4):366-70. PubMed ID: 18953247
[TBL] [Abstract][Full Text] [Related]
11. The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial.
Tsujino T; Isayama H; Nakai Y; Ito Y; Togawa O; Toda N; Arizumi T; Kogure H; Yamamoto K; Mizuno S; Yashima Y; Yagioka H; Sasaki T; Matsubara S; Yamamoto N; Hirano K; Sasahira N; Tada M; Koike K
J Gastroenterol; 2013 Aug; 48(8):982-8. PubMed ID: 23090004
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis: an updated meta-analysis.
Qin X; Lei WS; Xing ZX; Shi F
Saudi J Gastroenterol; 2015; 21(6):372-8. PubMed ID: 26655132
[TBL] [Abstract][Full Text] [Related]
13. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study.
Fujishiro H; Adachi K; Imaoka T; Hashimoto T; Kohge N; Moriyama N; Suetsugu H; Kawashima K; Komazawa Y; Ishimura N; Ishihara S; Amano Y; Kinoshita Y
J Gastroenterol Hepatol; 2006 Jun; 21(6):1065-9. PubMed ID: 16724996
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
[TBL] [Abstract][Full Text] [Related]
15. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
16. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
[TBL] [Abstract][Full Text] [Related]
17. Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis based on prospective, randomized, and controlled trials.
Xie Y; Cheng Z; Deng C; Deng M; Zhang H
Medicine (Baltimore); 2023 Oct; 102(41):e35174. PubMed ID: 37832051
[TBL] [Abstract][Full Text] [Related]
18. Gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis update.
Zheng MH; Bai JL; Meng MB; Chen YP
Curr Ther Res Clin Exp; 2008 Aug; 69(4):288-304. PubMed ID: 24692807
[TBL] [Abstract][Full Text] [Related]
19. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial.
Tsujino T; Komatsu Y; Isayama H; Hirano K; Sasahira N; Yamamoto N; Toda N; Ito Y; Nakai Y; Tada M; Matsumura M; Yoshida H; Kawabe T; Shiratori Y; Omata M
Clin Gastroenterol Hepatol; 2005 Apr; 3(4):376-83. PubMed ID: 15822043
[TBL] [Abstract][Full Text] [Related]
20. How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis.
Wan J; Ren Y; Zhu Z; Xia L; Lu N
BMC Gastroenterol; 2017 Mar; 17(1):43. PubMed ID: 28298192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
